Anant Pai

investing @generalcatalyst. not a scientist, so i ask a lot of questions.

DMs open. Views are my own.

[Anant Pai @theanantpai]

“cure all diseases” narrative is striking a chord w bio twitter

let’s use it as an opportunity. bio friends, what do you find most frustrating about tech tourists in the life sciences? most inspiring?

[Anant Pai @theanantpai]

@justjacehere hmmm… im sorta hoping they’re right

[Anant Pai @theanantpai]

“cure all diseases” narrative is striking a chord w bio twitter

let’s use it as an opportunity. bio friends, what do you find most frustrating about tech tourists in the life sciences? most inspiring?

[Anant Pai @theanantpai]

@ashleypaston oh my god

[Anant Pai @theanantpai]

@Yamato7xiu @Bodeeeman @permabear1993 @aditharun_ i try to assume good faith, and if you look closely, i don't really think that's what people are saying

[Anant Pai @theanantpai]

bio v bitter lesson - pick ur fighter

asked bio twitter what frustrates them about tech tourists. top answers:

- the clinic is the bottleneck, not the molecule (@Bodeeeman)
- nobody funds assay development (@permabear1993)
- biology isn't RL'able like code (@aditharun_)

most inspiring: the velocity. and the money

[Anant Pai @theanantpai]

“cure all diseases” narrative is striking a chord w bio twitter

let’s use it as an opportunity. bio friends, what do you find most frustrating about tech tourists in the life sciences? most inspiring?

[Anant Pai @theanantpai]

@brandonhli lolol

[Anant Pai @theanantpai]

@aditharun_ no i haven't but someone needs to put it together

[Anant Pai @theanantpai]

@MichaelaThinks couldn't agree more

[Anant Pai @theanantpai]

@metavestor ppl can be great ceo's and not great partners

[Anant Pai @theanantpai]

@aleximm v timely - asked bio twitter last night what frustrates them about tech in bio and the answer was basically the clinic, not the molecule. where do you think the gains in probability of success show up first?

[Anant Pai @theanantpai]

@leoleinclm bio v bitter lesson - pick ur fighter

[Anant Pai @theanantpai]

@ultravioliiii i dont understand what you mean by disregard or exclusion of regulatory capture? like you're just saying ppl aren't cognizant of the regulatory realities?

[Anant Pai @theanantpai]

@keatonminor maybe being more precise on what ai will or won't be able to do will be helpful

[Anant Pai @theanantpai]

@aditharun_ I think we need to get much more precise on what it means to "solve biology" - what is RL'able and what is not

[Anant Pai @theanantpai]

@SVDRECBD v fair - are there creative ways for labs to access funding from non government / donor sources of capital? seems like there's excitement to fund value-creating research from investors...

[Anant Pai @theanantpai]

@walheim_jonas agree - feels like more of the moonshots are getting funded by tech money now, and that's awesome.

Maybe virtual cell / digital twins aren't the answer on trials but we can all agree that something needs to change.

[Anant Pai @theanantpai]

@permabear1993 assay development also feels critical for scaling data collection for ai; we should def be spending more time on it

[Anant Pai @theanantpai]

@Bodeeeman yeah agree - more shots upstream doesn't help if clinical capital stays flat. who funds that? hopefully also some regulatory changes that can drive down the cost of trials

[Anant Pai @theanantpai]

@ns123abc https://t.co/Dr85gBadRI

[Anant Pai @theanantpai]

“cure all diseases” narrative is striking a chord w bio twitter

let’s use it as an opportunity. bio friends, what do you find most frustrating about tech tourists in the life sciences? most inspiring?

[Anant Pai @theanantpai]

what do you find most inspiring?